pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·1h ago·1 min read
save

Researchers warn long-term AI use may foster social isolation, call for better data access

Oct 26, 2026·read at STAT ↗Negative

An opinion piece by Cornell researchers raises the possibility that extended interaction with chatbots could gradually erode social connections, urging the scientific community to investigate this potential cumulative harm.

The authors note that OpenAI has begun tracking signs of user distress across multiple sessions and has introduced safeguards such as parental controls, usage limits, break reminders, and crisis‑detection referrals to address immediate mental‑health concerns.

Legislators are also stepping in, with several states now requiring chatbot operators to disclose that the tools are not human and to provide crisis‑referral procedures for users.

While these measures target acute risks, the writers argue that the industry and policymakers are overlooking longer‑term effects and call for broader data access so researchers can study whether AI use contributes to isolation over time.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “Opinion: Could long-term AI use lead to isolation? We need to find out — but researchers need better access to data”

read at STAT ↗
1,323 words · retrieved 29m ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

topics
Psychiatry & CNS6NeurologyOncology

related stories

  • May 8Giants of Cancer Care Announces the 14th Annual Class of Inducteesonclive
  • May 8OncLive Weekly News Quiz (5/8/2026): Test Your Knowledge on Key Breast, Lung, and Pancreatic Cancer Updatesonclive
  • May 8OncLive Polls Reveal Picks for Top Lung Cancer Abstracts at ASCO 2026onclive
  • May 8Poll Results Highlight Breast Cancer Abstracts of Interest at ASCO 2026onclive
  • May 8Lilly, Gilead lead pharma’s M&A boomBioPharma Dive